Final Results | Company Announcement
Investegate announcements from Final Results
Stay updated with breaking news from Milestone Payments. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from Final Results
Unaudited Condensed Interim Consolidated Financial Statements For the Six Months Ended December 31, 2023 and 2022 ...
Fast Track Designation and Strategic Collaborations Highlight Fiscal Year 2023
GSK said on Thursday it had completed the acquisition of Aiolos Bio, a clinical-stage biopharmaceutical company focused on respiratory and inflammatory conditions. GSK will pay $1 billion upfront and up to $400 million in success-based milestone payments. "In addition, GSK will also be responsible for success-based milestone payments as well as tiered royalties owed to Jiangsu Hengrui Pharmaceuticals Co, Ltd," the group said.
Revenue per available unit for FY 2023 grew 23% year-on-year to pre-pandemic levels Achieves about S$156 million or 2% increase in portfolio val...